Optimizing diagnostic pathways for myopathies with exercise intolerance: a random forest model approachThales Pardini Fagundes, Cláudia Ferreira da Rosa Sobreira, Karine Martins da Trindade et al.|Arquivos de Neuro-Psiquiatria|2024Cited by 0
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 StudyLisa Licitra, Song Qu, Ye Guo et al.|Journal of Clinical Oncology|2026Cited by 0